Group 1 - The celebration of the 100th anniversary of the All-China Federation of Trade Unions took place on April 28, highlighting the recognition of labor models and advanced workers across various sectors in Guangxi [1] - A total of 58 individuals from Guangxi were honored, including 39 national labor models and 19 advanced workers, showcasing a diverse representation from government, enterprises, and various professional fields [1] - The selection process for the awards emphasized transparency, fairness, and public participation, reflecting the importance of recognizing contributions to economic and social development in Guangxi over the past five years [1] Group 2 - The list of national labor models includes professionals from different industries, such as engineering, healthcare, and agriculture, indicating a broad spectrum of expertise and contributions [2][3][4] - Notable awardees include managers and engineers from prominent companies like Guangxi Nannan Aluminum Processing Co., Ltd. and SAIC-GM Wuling Automobile Co., Ltd., highlighting the role of industry leaders in driving innovation and productivity [2][3] - The recognition of advanced workers also features individuals from various sectors, including education, law enforcement, and healthcare, emphasizing the critical roles these professionals play in their communities [4][5]

Core Insights - Qingdao Bank's total assets have surpassed 700 billion yuan for the first time, reflecting its commitment to serving the local real economy [1] - The bank's corporate loans reached 279.56 billion yuan, marking a 6.56% increase from the beginning of the year [1] - Qingdao Bank has implemented a regional development strategy, focusing on localized decision-making and specialized services to support high-quality economic development [1] Talent Advantage and Support for Local Tech Enterprises - Qingdao Bank is actively promoting its "Five Major Articles" and conducting differentiated operations around "Eight Major Tracks" to support tech enterprises [2] - The bank has developed a "Qingyin Technology - Accompanying Growth" service system to address the financing challenges faced by light-asset, high-risk tech companies [2] - Qingdao Bank provided an 8 million yuan "Talent Loan" to Huasaiberman Medical Cell Biology Co., alleviating its financial pressures during its early stages [4] Support for Manufacturing and Livestock Industries - Qingdao Bank has established a unique financing solution for the livestock industry by creating a live livestock asset identification system, facilitating a loan of 288 million yuan for Qingdao Longming Cattle Industry [10][11] - The bank's support for the manufacturing sector includes a 200 million yuan credit approval for Beiqi Industrial Co., enabling the expansion of its production capacity [12] Customized Financial Services for Tourism Industry - Qingdao Bank has tailored financial services for the tourism industry, collaborating with local businesses like Pusu Hotel Management to provide flexible and efficient financial solutions [8] - The bank's customized financial plans have effectively supported the growth of the local tourism sector, particularly in managing cash flow during peak and off-peak seasons [8]

Investment Rating - The report maintains a "Buy" rating for 康方生物 (9926 HK) with a target price of HKD 115, indicating a potential upside of 16.3% from the current price of HKD 98.90 [7]. Core Insights - 康方生物's application for the PD-L1 positive NSCLC indication for its drug 依沃西 has been approved in mainland China earlier than expected, just 9 months after submission [1]. - The initial overall survival (OS) interim analysis from the HARMONi-2 study shows a hazard ratio (HR) of 0.777, indicating a 22.3% reduction in the risk of death, although it has not yet reached statistical significance [1]. - The report expresses optimism regarding the overseas development of 依沃西, particularly the ongoing HARMONi-7 study, which is expected to have a higher probability of achieving significant results due to a larger sample size and a focus on patients with higher PD-L1 expression [1]. Summary by Sections Approval and Clinical Data - The approval of 依沃西 for PD-L1 positive NSCLC in mainland China reflects regulatory confidence in the clinical benefits observed [1]. - The interim analysis of the HARMONi-2 study is based on a sample size of 398, with a low alpha allocation value of 0.0001, suggesting that the results may improve as more data matures [1][2]. Market Potential - The report forecasts peak sales of 61 billion RMB in mainland China and 5.7 billion USD overseas for 依沃西, highlighting its significant commercial potential [1]. - The upcoming data readout from the global Phase III HARMONi study for 2L EGFR+ NSCLC is anticipated to be a key event for investors [1]. Pipeline Developments - The report notes that the first clinical-stage antibody-drug conjugate (ADC) targeting HER3 has commenced enrollment in Australia, and a second ADC targeting TROP-2/Nectin-4 has received FDA clinical approval [1].

Group 1 - Jinzhongzi Liquor received approval from the Fuyang State-owned Assets Supervision and Administration Commission for the public transfer of 92% equity in its subsidiary, Anhui Jintaiyang Biochemical Pharmaceutical Co., Ltd. [1] - Sanlian Forging announced plans to establish a research institute for robotics and aerospace components to enhance its R&D capabilities in high-end manufacturing [1] - Anhui Heli's controlling shareholder, Anhui Forklift Group, obtained a loan commitment letter from CITIC Bank for a maximum of RMB 180 million to fund stock repurchases [1][2] Group 2 - Huaheng Biological appointed Zeng Miao as the company's securities affairs representative following an internal adjustment, ensuring the smooth operation of the board and information disclosure [2] - Anruisheng announced the partial lifting of the pledge on approximately 22.89 million shares held by its shareholder, Anhui Ruisheng New Energy Technology Development Co., Ltd. [2] - Conch Group, in collaboration with Huawei, launched the "AI + Cement and Building Materials Large Model," marking a significant step towards digital transformation in the cement and building materials industry [3]

Group 1 - Several private companies, including Zhongjie Automotive and Jiangshun Technology, successfully listed on the A-share market, raising over 45 billion yuan through various financing methods by April 27 [1] - The multi-level capital market in China is actively supporting the development of private enterprises, creating a vibrant and innovative environment for growth [3] - Approximately two-thirds of listed companies on the A-share market are private enterprises, with a significant presence in the ChiNext, Sci-Tech Innovation Board, and Beijing Stock Exchange [4] Group 2 - The private sector is showing resilience and vitality, with a number of leading companies reaching a market value of over 100 billion yuan, contributing to national economic growth and technological innovation [4] - The strategic emerging industries are favored by capital, with private enterprises in information technology and high-end equipment manufacturing accounting for 58% of the total financing [4] - The merger and acquisition market is becoming more active, with over 80 ongoing M&A cases in A-shares, of which more than 60% involve private enterprises [6] Group 3 - The bond market is expanding with various financing tools being introduced to support private enterprises, including the issuance of fixed-income products totaling 35.37 billion yuan in Shenzhen [7] - The Shanghai Stock Exchange has supported over 220 billion yuan in bond and asset-backed securities financing for more than 100 private enterprises in the past year [7] - The People's Bank of China and other regulatory bodies are expected to innovate and expand the issuance of private technology bonds [8] Group 4 - Regulatory bodies are focusing on enhancing the capital market to support technological innovation and the growth of private enterprises, with measures to improve market inclusivity and transparency [9] - In the first quarter of this year, private investment in China increased by 0.4%, with significant growth in manufacturing and infrastructure sectors [9] - Experts suggest further improvements in the multi-level capital market system to facilitate the listing of high-quality private enterprises and optimize the M&A process [10]

大部分肺结节检出者极度焦虑，调查显示，73%的检出者担心自己罹患肺癌，64%的认为自己需要手 术，57%的担心因结节死亡……因此，非常需要研发肺结节精准甄别的新技术。 "AI+基因检测"助力肺结节精准甄别 【深圳商报讯】（记者 张妍 通讯员 夏余飞）4月25日，国家科技重大专项"肺结节人工智能精准甄别技 术研发及应用研究"深圳发布会在大鹏新区坝光生物家园举行。该项目由四川大学华西医院牵头，联合 广州医科大学、中国人民解放军总医院及深圳泽医细胞治疗集团（以下简称"泽医集团"）等共同实施。 该项目将填补AI技术在肺癌早筛领域空白，通过"AI+基因检测"突破传统影像学依赖医生经验的局限， 降低误诊率，为肺癌早期防治提供更为高效、精准的技术手段。 肺结节是一个影像学术语，指的是肺部直径小于3厘米的圆形或类圆形阴影，并不是一个具体疾病的名 称。但肺结节病因复杂，其中约10%可能恶化为肺癌。 3月，国家科技重大专项《肺结节人工智能精准甄别技术研发及应用研究》获批立项启动。会上，该项 目的牵头人、四川大学华西医院呼吸与危重症医学科主任刘丹报告了项目规划。她指出，该项目通过已 有临床大队列，揭示肺结节风险因素，挖掘肺结节性质 ...

4月27日，副省长方伟赴镇江检查安全生产工作。省政府副秘书长徐华勤参加检查。市委常委、常 务副市长张克陪同检查。 在江苏金斯瑞生物科技有限公司，方伟深入企业生产和研发一线，详细了解企业安全管理体系建设 和安全生产责任制落实情况。得知企业建立了EHS基本安全准则，成立了安全生产委员会，配备专职安 全管理机构EHS部门，方伟给予肯定。他指出，生物科技行业技术密集、工艺复杂，安全风险点多、管 理要求高，企业必须树牢底线思维，强化安全管理，持续完善安全生产各项制度，提升本质安全水平， 切实将安全责任落实到每一个岗位、每一名员工。 随后，方伟来到镇江信缘康米山颐养院，实地检查消防控制室、消防设施设备运行状况以及疏散通 道设置情况，仔细询问火灾防控、应急预案制定、日常巡查制度和员工安全培训等工作落实情况。在认 真听取养老机构负责人介绍后，方伟指出，养老机构入住人员多为高龄老人，行动不便、应急反应能力 弱，消防安全责任重大。要深刻吸取近期各地火灾事故教训，进一步压实安全管理责任，全面开展风险 隐患排查整治，完善应急处置预案，加强员工技能培训和演练，做到早发现、早处置，确保遇到突发情 况能够及时组织有效应对，切实守护入住老人 ...

活动伊始，中欧国际工商学院管理学教授、中欧家族传承研究中心联合主任李秀娟带来主题演讲《她领 导力》。李秀娟认为，当女性逐渐走上职场舞台的正中央，担当领导者角色时，应该学会刚柔相济并运 用好自身的性别与能力优势，在不同阶段修炼不同的"领导力功课"，才能构筑自身的核心竞争力。 以下为演讲内容，经创业邦整理后发布。 困境：当"领导角色"与 "女性身份"正面交锋 作为这次榜单的评委，看到那些女性创业者和企业家的资料时，我心里真是感慨——中国真的是人才济 济。她们身上有三个特别鲜明的标签：高教育、高学识、高智慧。90%都是硕博学历，在各自行业里都是 响当当的精英，而最让我敬佩的，是她们那份"高勇气"。说实话，让我去创业我可能没那个胆子，但她 们敢从零开始打造自己的商业版图，这份胆识真的让人钦佩。 4月17日，创业邦2025璀璨女性影响力大会在北京举办，来自投资、科创、跨界领域的杰出女性共聚一 堂，分享洞察与商业科创实践，以热爱为炬，激励更多商业女性勇敢探索人生新篇章。 我在中欧国际工商学院教女性领导力课程，也见证了一个特别明显的变化：早年EMBA班里女性只占10% 多，现在快40%了，MBA和FMBA项目里女生更是占到 ...

"在税务部门的支持下，我们也越来越感受到合规经营的重要性。作为一家科创型社会企业，茵塞普对 外投资布局多元，业务体系复杂，只有税务、财务合规，企业才能走得远、走得好。"企业创始人余广 滔表示。 2020年，基于大湾区绿色环保及生物科技事业的高速发展，茵塞普科技将目光投向了深圳前海深港青年 梦工场。茵塞普科技负责人告诉记者，在税收优惠方面，研发费用加计扣除政策使茵塞普科技享受到相 关税收减免达100多万元，大幅降低了企业运营成本，让企业有更多资金投入到研发与生产环节。同 时，由深圳市税务局国际税收管理处、深圳市税务局第四税务分局、前海税务局在梦工场联合设立的税 务工作站也为茵塞普提供跨境税收优惠、多语种服务和国际税收咨询等专项税务服务支持，切实将便民 办税春风"吹"到企业发展的"心坎上"。 中国经济网深圳4月27日讯（记者 鞠然）近日，由中央网信办网络社会工作局、国家税务总局税收宣传 中心指导，深圳市委网信办、国家税务总局深圳市税务局联合主办的"合规经营 诚信纳税——看税收走 基层"主题网评活动走进深圳，来到了位于前海深港青年梦工场的茵塞普科技（深圳）有限公司。据了 解，前海深港青年梦工场是服务深港及世界青年创 ...

2025-2031全球与中国RNase清除剂市场竞争策略及投资可行性研究报告 【全新修订】：2025年4月 【出版机构】：中智信投研究网 【内容部分有删减·详细可参中智信投研究网出版完整信息！】 【免费售后 服务一年，具体内容及订购流程欢迎咨询客服人员 】 报告目录 1 RNase清除剂市场概述 1.1 产品定义及统计范围 1.2 按照不同产品类型，RNase清除剂主要可以分为如下几个类别 1.2.1 全球不同产品类型RNase清除剂销售额增长趋势2020 VS 2024 VS 2031 1.2.2 液相RNase清除剂 4.6 全球主要厂商RNase清除剂产品类型及应用 1.2.3 固相RNase清除剂 1.3 从不同应用，RNase清除剂主要包括如下几个方面 1.3.1 全球不同应用RNase清除剂销售额增长趋势2020 VS 2024 VS 2031 2.1.1 全球RNase清除剂产能、产量、产能利用率及发展趋势（2020-2031） 2.1.2 全球RNase清除剂产量、需求量及发展趋势（2020-2031） 1.3.2 医疗 1.3.3 科研 1.4 RNase清除剂行业背景、发展历史、现状及趋势 ...